In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy in the neurodegenerative Niemann Pick Type C1 (NPC1) disease mouse model. Imaging experiments were conducted with the most commonly studied mouse model of NPC1 disease at early and late disease states. High-resolution in vivo images were acquired at early and late stages of the disease and analyzed with atlas-based registration to obtain measurements of twenty brain region volumes. A two-way ANOVA analysis indicated eighteen of these regions were different due to genotype and thirteen showed a significant interaction with age and genotype. The ability to measure in vivo neurodegeneration evidenced by brain atrophy adds to the ability to monito...
Recent advance in NMR microimaging has enabled in vivo CBV mapping with high spatial resolution[1]. ...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
In humans, mutations of amyloid precursor protein (APP) and presenilins (PS) 1 and 2 are associated ...
In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy i...
Niemann Pick Type C (NPC) disease is a rare genetic disease which is most often diagnosed in childre...
Neuroimaging techniques represent powerful tools to assess disease-specific cellular, biochemical an...
AbstractNeuroimaging techniques represent powerful tools to assess disease-specific cellular, bioche...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Magnetic resonance imaging (MRI) has proved to be an ideal modality for non-destructive and highly d...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease ( HD ) is a genetically-determined neurodegenerative disease. Characterising ne...
Recent advance in NMR microimaging has enabled in vivo CBV mapping with high spatial resolution[1]. ...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
In humans, mutations of amyloid precursor protein (APP) and presenilins (PS) 1 and 2 are associated ...
In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy i...
Niemann Pick Type C (NPC) disease is a rare genetic disease which is most often diagnosed in childre...
Neuroimaging techniques represent powerful tools to assess disease-specific cellular, biochemical an...
AbstractNeuroimaging techniques represent powerful tools to assess disease-specific cellular, bioche...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Magnetic resonance imaging (MRI) has proved to be an ideal modality for non-destructive and highly d...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising neur...
Huntington’s disease ( HD ) is a genetically-determined neurodegenerative disease. Characterising ne...
Recent advance in NMR microimaging has enabled in vivo CBV mapping with high spatial resolution[1]. ...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
In humans, mutations of amyloid precursor protein (APP) and presenilins (PS) 1 and 2 are associated ...